Navigation Links
Independent Study Concludes Medicare 'Competitive' Bidding Program for Durable Medical Equipment Could Negatively Affect Care Access, Quality, and Choice for Seniors and People with Disabilities
Date:9/14/2010

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- A new study conducted by Dobson | DaVanzo & Associates found that the Medicare "competitive" bidding program for durable medical equipment (DME) may limit Medicare beneficiaries' access to home medical equipment and services and could reduce the quality of products that Medicare consumers rely on.  

DME providers serve the medical needs of millions of Americans who require oxygen equipment and therapy, mobility assistive technologies, medical supplies, inhalation drug therapy, home infusion, and other home medical equipment, therapies, services, and supplies in the home. The bidding program for home medical equipment and services is scheduled to take effect in nine metropolitan statistical areas in the U.S. in January 2011 including Charlotte, Cincinnati, Cleveland, Dallas-Fort Worth, Kansas City, Miami, Orlando, Pittsburgh, and Riverside, Calif.  An additional 91 areas are scheduled to start the bidding program later in 2011.

The report was released the day before a House Energy and Commerce subcommittee scheduled a hearing on the controversial bidding program.

"There are several problems inherent in CMS's design of the competitive bidding process that create perverse incentives and may result in unsustainable low bids from suppliers," concluded Dobson | DaVanzo in its report, "The Risks to Medicare Beneficiaries of DMEPOS (durable medical equipment, prosthetics, orthotics, and supplies) Competitive Bidding – Considerations for Round 1 Re-Bid and Beyond."  

"Furthermore, the competitive bidding program design does not provide beneficiaries with adequate protections against degradation in care or service."

"The results of DMEPOS provider competition based on price, rather than quality of supplies or customer service, may result in significant reductions to the quality of items and services beneficiaries need to remain at home, independently," states the report.  "Unintended consequences that could result include secondary medical complications, increased emergency department visits and hospital discharge delays, and ultimately, a transition out of the home to more costly facility-based care."

Key findings on the potential repercussions of the so-called Medicare "competitive" bidding program include:

  • Negative Marketplace Implications: The design of the program creates economic incentives that could produce unsustainably low prices and lead to reduced quality and service for Medicare beneficiaries.
  • Limited Choice: Freedom of choice will be challenged for beneficiaries, both in terms of types of suppliers and types of equipment that will be available.
  • Reduced Access: As the number of suppliers is reduced, beneficiaries could experience problems accessing quality equipment and services, especially by geographic area and over time.
  • Less Quality: Under dramatically lowered prices, suppliers may not be able to provide high quality products, and may significantly reduce the services they provide to beneficiaries.

H.R. 3790, a bipartisan bill that replaces the Medicare bidding program with other types of cost-savings, would reduce reimbursements to home medical equipment providers but preserve patient access to medically required equipment and services in the home.  So far, the bill has 255 cosponsors in the U.S. House of Representatives with broad bipartisan support. More than half of both the Democratic and Republican delegations in the House support H.R. 3790.

Patient and consumer groups that support the elimination of Medicare's "competitive" bidding program for durable medical equipment include the ALS Association, the American Association for Respiratory Care, the American Association of People with Disabilities, International Ventilator Users Network, the Muscular Dystrophy Association, National Emphysema/COPD Association, National Spinal Cord Injury Association, and Post-Polio Health International, among others.

The report, commissioned by the American Association for Homecare, was intended to educate policymakers about the risks posed by the DMEPOS bidding program. See the full text at www.aahomecare.org/competitivebidding. A member of the American Association for Homecare will testify at Wednesday's Energy and Commerce subcommittee hearing.

Dobson | DaVanzo conducted interviews with patient advocates, beneficiaries, hospital discharge planners, academic experts, former CMS officials and contractors, and providers in the DME community. The firm also reviewed government reports, congressional testimony, and journal articles to examine the potential impact of the program.

Dobson DaVanzo & Associates, LLC is a health care economics consulting firm based in the Washington, DC, metropolitan area. The work of the principals has influenced numerous public policy decisions and appears in legislation and regulation. Dobson | DaVanzo researchers have provided testimony to the Centers for Medicare and Medicaid Services (CMS), the Medicare Payment Advisory Commission (MedPAC), and the U.S. Treasury, as well as before members of Congress, state legislatures, and numerous stakeholder groups.

The American Association for Homecare represents durable medical equipment providers, manufacturers, and other organizations in the homecare community. Members serve the medical needs of millions of Americans who require oxygen equipment and therapy, mobility assistive technologies, medical supplies, inhalation drug therapy, home infusion, and other medical equipment and services in their homes. The Association's members operate more than 3,000 homecare locations in all 50 states. Visit www.aahomecare.org/competitivebidding.


'/>"/>
SOURCE American Association for Homecare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. Independent Clinical Results Confirm Up to a 7-Centimeter Reduction in Body Circumference Using UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring System
4. Independent Physician Surveys Show if Approved, MF101 Could Become First-Line Treatment for Menopause Symptoms
5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
6. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
7. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
8. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Promise of Vicals CMV Vaccine Noted by Independent Experts
11. ASPIRE Independent Review Board Announces 10 Ways to Protect Participants Rights in Clinical Drug Trials and Optimize Results From Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):